CLL Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
R
Active, not recruiting
  • CLL
  • Vaccine Response
  • PCV13
  • PPSV23
  • Örebro, Sweden
    Magdalena Kättström
2022-03-29
Mar 29, 2022
S
Terminated
  • Chronic Lymphocytic Leukemia
  • +3 more
  • TP-0903
  • TP-0903 and ibrutinib combination therapy
  • Phoenix, Arizona
  • +5 more
2022-04-04
Apr 4, 2022
G
Recruiting
  • B Cell NHL
  • CLL
  • GB261
  • Melbourne, The State Of Victoria, Australia
  • +2 more
2022-04-01
Apr 1, 2022
U
Recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
    • Bobigny, France
    • +8 more
    2022-03-23
    Mar 23, 2022
    T
    Recruiting
    • CLL
    • +9 more
    • TG-1801
    • Ublituximab
    • Fayetteville, Arkansas
    • +4 more
    2022-03-22
    Mar 22, 2022
    M
    Withdrawn
    • CLL
    • +4 more
    • Treatment Free Observation
    • Basking Ridge, New Jersey
    • +8 more
    2022-03-04
    Mar 4, 2022
    M
    Completed
    • CLL
    • Leukemia
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    2022-03-14
    Mar 14, 2022
    C
    Recruiting
    • Malignancy
    • +14 more
    • Scottsdale, Arizona
    • +17 more
    2022-03-07
    Mar 7, 2022
    T
    Completed
    • CLL
      • Tampere, Finland
        Tampere university Hospital
      2022-02-22
      Feb 22, 2022
      M
      Not yet recruiting
      • CLL
      • (no location specified)
      2022-02-08
      Feb 8, 2022
      D
      Suspended
      • Blood Pressure
      • +6 more
      • Automated Messaging
      • Durham, North Carolina
        Duke University Medical Center
      2022-01-21
      Jan 21, 2022
      U
      Recruiting
      • CLL
      • B-cell Non Hodgkin Lymphoma
      • New Haven, Connecticut
      • +2 more
      2022-01-07
      Jan 7, 2022
      G
      Recruiting
      • CLL
      • +7 more
        • Dresden, Sachsen, Germany
          BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
        2021-12-16
        Dec 16, 2021
        G
        Recruiting
        • CLL
        • Chronic Lymphocytic Leukemia
        • Peripheral blood samples withdrawal
        • Milano, Italy
        • +1 more
        2022-01-03
        Jan 3, 2022
        N
        Active, not recruiting
        • Multiple Myeloma
        • +4 more
        • Total Body Irradiation
        • +5 more
        • Los Angeles, California
          Cedars Sinai Medical Center
        2021-12-01
        Dec 1, 2021
        V
        Withdrawn
        • Chronic Lymphocytic Leukemia
        • +8 more
        • Dose combination 1-1
        • +5 more
        • (no location specified)
        2021-11-01
        Nov 1, 2021
        M
        Active, not recruiting
        • CLL
        • Standard of Care
        • Buenos Aires, Argentina
          Fundaleu
        2021-10-15
        Oct 15, 2021
        U
        Active, not recruiting
        • Chronic Lymphocytic Leukemia
        • CLL
        • La Jolla, California
          University of California, San Diego
        2021-09-02
        Sep 2, 2021
        S
        Active, not recruiting
        • CLL
        • ibrutinib, venetoclax, obinutuzumab
        • ibrutinib, venetoclax
        • Aalborg, Denmark
        • +26 more
        2021-08-20
        Aug 20, 2021
        G
        Completed
        • NHL
        • +17 more
        • veltuzumab
        • Savannah, Georgia
        • +4 more
        2021-08-12
        Aug 12, 2021
        T
        Active, not recruiting
        • CLL
        • +2 more
          • Tel Aviv, Israel
            Tel-Aviv Sourasky Medical Center
          2021-08-08
          Aug 8, 2021
          A
          Active, not recruiting
          • Follicular Lymphoma (FL)
          • +12 more
          • Tucson, Arizona
          • +18 more
          2021-06-17
          Jun 17, 2021